Telemedicine: an Effective and Low-Cost Lesson From the COVID-19 Pandemic for the Management of Heart Failure Patients
Authors:
Open Access
- 4 September 2023
- journal article
- research article
- Published by Springer Nature in Current Heart Failure Reports
- Vol. 20 (5) , 382-389
Abstract
Purpose: The purpose of this review is to explore the benefits and controversies that telemedicine (TM), applied to patients with heart failure (HF), can provide in terms of diagnosis, therapeutic management, and prognosis improvement. Recent Findings and Summary: During the coronavirus disease 19 (COVID-19) outbreak, TM emerged as the most effective and feasible method available to ensure continuous care for chronic diseases. Among these, HF, characterized by high mortality, morbidity, and the need for frequent visits, may benefit of the TM role. HF patients are affected by frequent exacerbations undergoing a progressive prognosis impoverishment, strongly depending on the disease’s management. A precise clinical handling is always required, with a constant optimization of the therapy, a continuous control of risk factors, and a sensitive attention to any change in symptoms, clinical signs, and laboratory tests. In this context, TM has shown to improve therapy adherence and HF: patients’ self-care, impacting the prognosis even if specific results are controversial. Major evidence shows that TM may allow an adequate primary prevention, reducing the impact of the main cardiovascular risk factors. TM can also be useful for the secondary prevention, early detecting a likely HF exacerbation before it becomes clinically manifest, thereby lowering the need for hospitalization. Moreover, an optimal up-titration of the therapy and an increase in treatment adherence are feasible by using TM. However, some studies did not show unambiguous results, and uncertainties still remain. GraphicalKeywords
Funding Information
- Università degli Studi di Roma La Sapienza
This publication has 51 references indexed in Scilit:
- The role of mHealth for improving medication adherence in patients with cardiovascular disease: a systematic reviewEuropean Heart Journal - Quality of Care and Clinical Outcomes, 2016
- Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trialThe Lancet, 2016
- Effect of Lifestyle-Focused Text Messaging on Risk Factor Modification in Patients With Coronary Heart DiseaseJAMA, 2015
- Randomized controlled feasibility trial of two telemedicine medication reminder systems for older adults with heart failureJournal of Telemedicine and Telecare, 2014
- Twenty years of telemedicine in chronic disease management – an evidence synthesisJournal of Telemedicine and Telecare, 2012
- Impact of Remote Telemedical Management on Mortality and Hospitalizations in Ambulatory Patients With Chronic Heart FailureCirculation, 2011
- Telemonitoring in Patients with Heart FailureNew England Journal of Medicine, 2010
- Compliance in heart failure patients: the importance of knowledge and beliefsEuropean Heart Journal, 2005
- Diabetes and cardiovascular risk factors: the Framingham study.Circulation, 1979
- An experimental evaluation of alternative communication systems as used for medical diagnosisSystems Research and Behavioral Science, 1975